Monday, April 29, 2024
ADVT 
International

In U.S., Europe, hope about future health crises

Darpan News Desk The Canadian Press, 03 Feb, 2021 06:03 PM
  • In U.S., Europe, hope about future health crises

A new poll suggests people in the United States and parts of Europe believe their countries will be better equipped to handle the next major health crisis.

The Pew Research Center poll out today finds optimism for the future among a majority of 4,000 respondents in the U.S., the United Kingdom, France and Germany.

In Europe, that optimism was strongest among those who already believe their countries have done a good job in the fight against COVID-19.

In the U.S., however, confidence in the future is high — 67 per cent — regardless of whether respondents were disappointed or satisfied by the government's handling of the pandemic.

The poll, conducted by phone in November and December, carries a margin of error of between 3.7 and 4.2 percentage points, depending on the country surveyed.

It found a growing percentage of respondents in all four countries said COVID-19 had changed their lives significantly, including 74 per cent in the U.S. and 70 per cent in the U.K.

The poll did not survey Canadians, but the country took a big step Tuesday towards equipping itself for the next viral outbreak.

The federal government is ramping up Canada's capacity to manufacture vaccines, with plans to make the Novavax shot the first of its kind to be made domestically.

The poll also asked respondents how they would feel if their respective governments were to make a safe and effective COVID-19 vaccine mandatory.

Only in the U.K. did a majority of those surveyed, 62 per cent, said they would find such a policy acceptable. In France, 75 per cent of respondents said they would be opposed to a mandatory vaccine policy.

In the U.S., 57 per cent said they opposed the idea, but a much larger gap emerged when the results were divided along partisan lines.

Only 28 per cent of those who identified as conservatives said they would support requiring vaccination, compared to 60 per cent of U.S. liberals.

More broadly, a growing majority of respondents in the U.S., the U.K. and France said their lives had changed due to COVID-19.

Only in Germany did fewer than half of those surveyed say the virus had changed their lives either "a fair amount" or "a great deal." But even there, 47 per cent described significant change, up from 39 per cent in June.

In all four countries, a higher percentage of women described a significant impact from COVID-19 — a likely reflection of research that shows women losing their jobs at a higher rate than men.

MORE International ARTICLES

WATCH: France Alert as Terrorist Strikes Nice Again | "Islamic Terrorism" says President Macron

WATCH: France Alert as Terrorist Strikes Nice Again |
WATCH: A deadly terrorist attack has targeted France. According to Police, three people have been killed in a knife attack at a church in the French city of Nice.

WATCH: France Alert as Terrorist Strikes Nice Again | "Islamic Terrorism" says President Macron

Trump formally lets Canadian aluminum off hook

Trump formally lets Canadian aluminum off hook
The U.S. president formally signed a proclamation today exempting Canadian aluminum exports from punitive Section 232 tariffs.

Trump formally lets Canadian aluminum off hook

Prince Harry says ignorance no excuse for unconscious bias

Prince Harry says ignorance no excuse for unconscious bias
Harry talked about racial inequality and social justice in a video discussion with the Black Lives Matter activist Patrick Hutchinson as part of the GQ Heroes Conference, which is being broadcast this week.

Prince Harry says ignorance no excuse for unconscious bias

Halloween goes on at the White House with a few twists

Halloween goes on at the White House with a few twists
In years past, the president and first lady personally handed out candy to the costume-clad kids. This year, the treats were provided separately as participants walked along a path on the South Lawn.

Halloween goes on at the White House with a few twists

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir